Hjem › Geografisk atrofi › Florida
Geografisk atrofi kliniske forsøg i Florida
8 studier for Geografisk atrofi søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina Group of Florida, Fort Lauderdale
- VitreoRetinal Associates, PA, Gainesville
- Retina Specialty Institute, Pensacola
- og 1 flere
RekruttererFase 2/3
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Vitreo Retinal Associates - Gainesville- Site Number : 8400004, Gainesville
- Retina Vitreous Associates of Florida - St. Petersburg- Site Number : 8400002, St. Petersburg
RekruttererFase 1/2
Alder 60 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07215234A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Advanced Retina Institute-Ophthalmology, Bonita Springs
- Advanced Research, Coral Springs
- Retina Group of Florida, Fort Lauderdale
- og 11 flere
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- Retina Vitreous Associates of Florida, St. Petersburg
RekruttererFase 2
Alder 50 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Florida Retina Institute, Orlando
- Retina Specialty Institute, Pensacola
- Retina Group of Florida, Sarasota
- og 1 flere
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Retina Specialty Institute, Pensacola
RekruttererFase 1
Alder 50 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT03178149Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT03011541Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Sarasota Retina Institute, Sarasota
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 3. dec. 2024 · NCT05438732Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.